 | • レポートコード：GIR201111239 • 出版社/出版日：GlobalInfoResearch / 2020年10月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、130ページ • 納品方法：Eメール • 産業分類：医薬品・医療 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本書では、GABA受容体作動薬の世界市場を調査対象にし、GABA受容体作動薬の市場概要、メーカー情報、メーカー別販売量・売上・市場シェア、地域別市場分析（北米、アメリカ、ヨーロッパ、アジア、日本、中国、南米、中東・アフリカ）、種類別分析（バマルゾール、フェニバット、バクロフェン、ガボクサドール、クロノピン（クロナゼパム）、ティアグビン）、用途別分析（注意欠陥多動性障害（ADHD）、精神障害及びうつ病、アルツハイマー、てんかん及び発作、不安及び睡眠障害、肥満及びアルコール依存症）、市場予測（2021年～2025年）、販売チャンネル・代理店分析情報などを整理しました。 ・市場概要 ・メーカー情報：Advicenne、GlaxoSmithKline、Biocodex、AstraZeneca、H.LundBeck, Merck and Co、Athena Drug Delivery Solutions、Novartis、Eli Lilly and Company、Elan Corporation、NovaDel Pharma、VIVUS、OVATION Pharmaceuticals、XenoPort、sanofi-aventis、Osmotica Pharmaceutical、Pfizer ・メーカー別販売量、売上、市場シェア ・GABA受容体作動薬の地域別市場分析 ・GABA受容体作動薬の北米市場規模2015-2020：アメリカ、カナダ、メキシコ ・GABA受容体作動薬のヨーロッパ市場規模2015-2020：ドイツ、イギリス、フランス、ロシアなど ・GABA受容体作動薬のアジア市場規模2015-2020：日本、中国、韓国、インド、東南アジアなど ・GABA受容体作動薬の南米市場規模2015-2020：ブラジル、アルゼンチンなど ・GABA受容体作動薬の中東・アフリカ市場規模2015-2020：サウジアラビア、トルコ、エジプト、南アフリカなど ・GABA受容体作動薬の種類別市場規模2015-2020：バマルゾール、フェニバット、バクロフェン、ガボクサドール、クロノピン（クロナゼパム）、ティアグビン ・GABA受容体作動薬の用途別市場規模2015-2020：注意欠陥多動性障害（ADHD）、精神障害及びうつ病、アルツハイマー、てんかん及び発作、不安及び睡眠障害、肥満及びアルコール依存症 ・GABA受容体作動薬の世界市場予測2021-2025：地域別、種類別、用途別 ・販売チャンネル・代理店分析 ・調査の結果・結論 |
Market Overview
The global GABA Receptor Agonist Drug market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The GABA Receptor Agonist Drug market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
GABA Receptor Agonist Drug market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, GABA Receptor Agonist Drug market has been segmented into
Bamaluzole
Phenibut
Baclofen
Gaboxadol
Klonopin (clonazepam)
Tiagbine
By Application, GABA Receptor Agonist Drug has been segmented into:
Attention Deficit Hyperactivity Disorder (ADHD)
Psychiatric Disorders and Depression
Alzheimer
Epilepsy and Seizure
Anxiety and Sleep Disorders
Obesity and Alcoholism
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global GABA Receptor Agonist Drug market presented in the report. This section sheds light on the sales growth of different regional and country-level GABA Receptor Agonist Drug markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global GABA Receptor Agonist Drug market.
The report offers in-depth assessment of the growth and other aspects of the GABA Receptor Agonist Drug market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)
Competitive Landscape and GABA Receptor Agonist Drug Market Share Analysis
GABA Receptor Agonist Drug competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, GABA Receptor Agonist Drug sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the GABA Receptor Agonist Drug sales, revenue and market share for each player covered in this report.
The major players covered in GABA Receptor Agonist Drug are:
Advicenne
GlaxoSmithKline
Biocodex
AstraZeneca
H.LundBeck, Merck and Co
Athena Drug Delivery Solutions
Novartis
Eli Lilly and Company
Elan Corporation
NovaDel Pharma
VIVUS
OVATION Pharmaceuticals
XenoPort
sanofi-aventis
Osmotica Pharmaceutical
Pfizer
Among other players domestic and global, GABA Receptor Agonist Drug market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe GABA Receptor Agonist Drug product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of GABA Receptor Agonist Drug, with price, sales, revenue and global market share of GABA Receptor Agonist Drug in 2018 and 2019.
Chapter 3, the GABA Receptor Agonist Drug competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the GABA Receptor Agonist Drug breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, GABA Receptor Agonist Drug market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe GABA Receptor Agonist Drug sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Table of Contents
1 Market Overview
1.1 GABA Receptor Agonist Drug Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global GABA Receptor Agonist Drug Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Bamaluzole
1.2.3 Phenibut
1.2.4 Baclofen
1.2.5 Gaboxadol
1.2.6 Klonopin (clonazepam)
1.2.7 Tiagbine
1.3 Market Analysis by Application
1.3.1 Overview: Global GABA Receptor Agonist Drug Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Attention Deficit Hyperactivity Disorder (ADHD)
1.3.3 Psychiatric Disorders and Depression
1.3.4 Alzheimer
1.3.5 Epilepsy and Seizure
1.3.6 Anxiety and Sleep Disorders
1.3.7 Obesity and Alcoholism
1.4 Overview of Global GABA Receptor Agonist Drug Market
1.4.1 Global GABA Receptor Agonist Drug Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Advicenne
2.1.1 Advicenne Details
2.1.2 Advicenne Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Advicenne SWOT Analysis
2.1.4 Advicenne Product and Services
2.1.5 Advicenne GABA Receptor Agonist Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 GlaxoSmithKline
2.2.1 GlaxoSmithKline Details
2.2.2 GlaxoSmithKline Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 GlaxoSmithKline SWOT Analysis
2.2.4 GlaxoSmithKline Product and Services
2.2.5 GlaxoSmithKline GABA Receptor Agonist Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Biocodex
2.3.1 Biocodex Details
2.3.2 Biocodex Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Biocodex SWOT Analysis
2.3.4 Biocodex Product and Services
2.3.5 Biocodex GABA Receptor Agonist Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 AstraZeneca
2.4.1 AstraZeneca Details
2.4.2 AstraZeneca Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 AstraZeneca SWOT Analysis
2.4.4 AstraZeneca Product and Services
2.4.5 AstraZeneca GABA Receptor Agonist Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 H.LundBeck, Merck and Co
2.5.1 H.LundBeck, Merck and Co Details
2.5.2 H.LundBeck, Merck and Co Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 H.LundBeck, Merck and Co SWOT Analysis
2.5.4 H.LundBeck, Merck and Co Product and Services
2.5.5 H.LundBeck, Merck and Co GABA Receptor Agonist Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 Athena Drug Delivery Solutions
2.6.1 Athena Drug Delivery Solutions Details
2.6.2 Athena Drug Delivery Solutions Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Athena Drug Delivery Solutions SWOT Analysis
2.6.4 Athena Drug Delivery Solutions Product and Services
2.6.5 Athena Drug Delivery Solutions GABA Receptor Agonist Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 Novartis
2.7.1 Novartis Details
2.7.2 Novartis Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Novartis SWOT Analysis
2.7.4 Novartis Product and Services
2.7.5 Novartis GABA Receptor Agonist Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.8 Eli Lilly and Company
2.8.1 Eli Lilly and Company Details
2.8.2 Eli Lilly and Company Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Eli Lilly and Company SWOT Analysis
2.8.4 Eli Lilly and Company Product and Services
2.8.5 Eli Lilly and Company GABA Receptor Agonist Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.9 Elan Corporation
2.9.1 Elan Corporation Details
2.9.2 Elan Corporation Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Elan Corporation SWOT Analysis
2.9.4 Elan Corporation Product and Services
2.9.5 Elan Corporation GABA Receptor Agonist Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.10 NovaDel Pharma
2.10.1 NovaDel Pharma Details
2.10.2 NovaDel Pharma Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 NovaDel Pharma SWOT Analysis
2.10.4 NovaDel Pharma Product and Services
2.10.5 NovaDel Pharma GABA Receptor Agonist Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.11 VIVUS
2.11.1 VIVUS Details
2.11.2 VIVUS Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 VIVUS SWOT Analysis
2.11.4 VIVUS Product and Services
2.11.5 VIVUS GABA Receptor Agonist Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.12 OVATION Pharmaceuticals
2.12.1 OVATION Pharmaceuticals Details
2.12.2 OVATION Pharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
2.12.3 OVATION Pharmaceuticals SWOT Analysis
2.12.4 OVATION Pharmaceuticals Product and Services
2.12.5 OVATION Pharmaceuticals GABA Receptor Agonist Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.13 XenoPort
2.13.1 XenoPort Details
2.13.2 XenoPort Major Business and Total Revenue (Financial Highlights) Analysis
2.13.3 XenoPort SWOT Analysis
2.13.4 XenoPort Product and Services
2.13.5 XenoPort GABA Receptor Agonist Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.14 sanofi-aventis
2.14.1 sanofi-aventis Details
2.14.2 sanofi-aventis Major Business and Total Revenue (Financial Highlights) Analysis
2.14.3 sanofi-aventis SWOT Analysis
2.14.4 sanofi-aventis Product and Services
2.14.5 sanofi-aventis GABA Receptor Agonist Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.15 Osmotica Pharmaceutical
2.15.1 Osmotica Pharmaceutical Details
2.15.2 Osmotica Pharmaceutical Major Business and Total Revenue (Financial Highlights) Analysis
2.15.3 Osmotica Pharmaceutical SWOT Analysis
2.15.4 Osmotica Pharmaceutical Product and Services
2.15.5 Osmotica Pharmaceutical GABA Receptor Agonist Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.16 Pfizer
2.16.1 Pfizer Details
2.16.2 Pfizer Major Business and Total Revenue (Financial Highlights) Analysis
2.16.3 Pfizer SWOT Analysis
2.16.4 Pfizer Product and Services
2.16.5 Pfizer GABA Receptor Agonist Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global GABA Receptor Agonist Drug Sales and Market Share by Manufacturer (2018-2019)
3.2 Global GABA Receptor Agonist Drug Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 GABA Receptor Agonist Drug Manufacturer Market Share in 2019
3.3.2 Top 6 GABA Receptor Agonist Drug Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global GABA Receptor Agonist Drug Sales, Revenue and Market Share by Regions
4.1.1 Global GABA Receptor Agonist Drug Sales and Market Share by Regions (2015-2020)
4.1.2 Global GABA Receptor Agonist Drug Revenue and Market Share by Regions (2015-2020)
4.2 North America GABA Receptor Agonist Drug Sales and Growth Rate (2015-2020)
4.3 Europe GABA Receptor Agonist Drug Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific GABA Receptor Agonist Drug Sales and Growth Rate (2015-2020)
4.5 South America GABA Receptor Agonist Drug Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa GABA Receptor Agonist Drug Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America GABA Receptor Agonist Drug Sales, Revenue and Market Share by Country
5.1.1 North America GABA Receptor Agonist Drug Sales and Market Share by Country (2015-2020)
5.1.2 North America GABA Receptor Agonist Drug Revenue and Market Share by Country (2015-2020)
5.2 United States GABA Receptor Agonist Drug Sales and Growth Rate (2015-2020)
5.3 Canada GABA Receptor Agonist Drug Sales and Growth Rate (2015-2020)
5.4 Mexico GABA Receptor Agonist Drug Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe GABA Receptor Agonist Drug Sales, Revenue and Market Share by Country
6.1.1 Europe GABA Receptor Agonist Drug Sales and Market Share by Country (2015-2020)
6.1.2 Europe GABA Receptor Agonist Drug Revenue and Market Share by Country (2015-2020)
6.2 Germany GABA Receptor Agonist Drug Sales and Growth Rate (2015-2020)
6.3 UK GABA Receptor Agonist Drug Sales and Growth Rate (2015-2020)
6.4 France GABA Receptor Agonist Drug Sales and Growth Rate (2015-2020)
6.5 Russia GABA Receptor Agonist Drug Sales and Growth Rate (2015-2020)
6.6 Italy GABA Receptor Agonist Drug Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific GABA Receptor Agonist Drug Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific GABA Receptor Agonist Drug Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific GABA Receptor Agonist Drug Revenue and Market Share by Regions (2015-2020)
7.2 China GABA Receptor Agonist Drug Sales and Growth Rate (2015-2020)
7.3 Japan GABA Receptor Agonist Drug Sales and Growth Rate (2015-2020)
7.4 Korea GABA Receptor Agonist Drug Sales and Growth Rate (2015-2020)
7.5 India GABA Receptor Agonist Drug Sales and Growth Rate (2015-2020)
7.6 Southeast Asia GABA Receptor Agonist Drug Sales and Growth Rate (2015-2020)
7.7 Australia GABA Receptor Agonist Drug Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America GABA Receptor Agonist Drug Sales, Revenue and Market Share by Country
8.1.1 South America GABA Receptor Agonist Drug Sales and Market Share by Country (2015-2020)
8.1.2 South America GABA Receptor Agonist Drug Revenue and Market Share by Country (2015-2020)
8.2 Brazil GABA Receptor Agonist Drug Sales and Growth Rate (2015-2020)
8.3 Argentina GABA Receptor Agonist Drug Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa GABA Receptor Agonist Drug Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa GABA Receptor Agonist Drug Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa GABA Receptor Agonist Drug Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia GABA Receptor Agonist Drug Sales and Growth Rate (2015-2020)
9.3 Turkey GABA Receptor Agonist Drug Sales and Growth Rate (2015-2020)
9.4 Egypt GABA Receptor Agonist Drug Sales and Growth Rate (2015-2020)
9.5 South Africa GABA Receptor Agonist Drug Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global GABA Receptor Agonist Drug Sales and Market Share by Type (2015-2020)
10.2 Global GABA Receptor Agonist Drug Revenue and Market Share by Type (2015-2020)
10.3 Global GABA Receptor Agonist Drug Price by Type (2015-2020)
11 Global GABA Receptor Agonist Drug Market Segment by Application
11.1 Global GABA Receptor Agonist Drug Sales Market Share by Application (2015-2020)
11.2 Global GABA Receptor Agonist Drug Revenue Market Share by Application (2015-2020)
11.3 Global GABA Receptor Agonist Drug Price by Application (2015-2020)
12 Market Forecast
12.1 Global GABA Receptor Agonist Drug Sales, Revenue and Growth Rate (2021-2025)
12.2 GABA Receptor Agonist Drug Market Forecast by Regions (2021-2025)
12.2.1 North America GABA Receptor Agonist Drug Market Forecast (2021-2025)
12.2.2 Europe GABA Receptor Agonist Drug Market Forecast (2021-2025)
12.2.3 Asia-Pacific GABA Receptor Agonist Drug Market Forecast (2021-2025)
12.2.4 South America GABA Receptor Agonist Drug Market Forecast (2021-2025)
12.2.5 Middle East & Africa GABA Receptor Agonist Drug Market Forecast (2021-2025)
12.3 GABA Receptor Agonist Drug Market Forecast by Type (2021-2025)
12.3.1 Global GABA Receptor Agonist Drug Sales Forecast by Type (2021-2025)
12.3.2 Global GABA Receptor Agonist Drug Market Share Forecast by Type (2021-2025)
12.4 GABA Receptor Agonist Drug Market Forecast by Application (2021-2025)
12.4.1 Global GABA Receptor Agonist Drug Sales Forecast by Application (2021-2025)
12.4.2 Global GABA Receptor Agonist Drug Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US
Table 1. Global GABA Receptor Agonist Drug Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of GABA Receptor Agonist Drug by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global GABA Receptor Agonist Drug Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Market Opportunities in Next Few Years
Table 5. Market Risks Analysis
Table 6. Market Drivers
Table 7. Advicenne Basic Information, Manufacturing Base and Competitors
Table 8. Advicenne GABA Receptor Agonist Drug Major Business
Table 9. Advicenne GABA Receptor Agonist Drug Total Revenue (USD Million) (2018-2019)
Table 10. Advicenne SWOT Analysis
Table 11. Advicenne GABA Receptor Agonist Drug Product and Services
Table 12. Advicenne GABA Receptor Agonist Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 13. GlaxoSmithKline Basic Information, Manufacturing Base and Competitors
Table 14. GlaxoSmithKline GABA Receptor Agonist Drug Major Business
Table 15. GlaxoSmithKline GABA Receptor Agonist Drug Total Revenue (USD Million) (2018-2019)
Table 16. GlaxoSmithKline SWOT Analysis
Table 17. GlaxoSmithKline GABA Receptor Agonist Drug Product and Services
Table 18. GlaxoSmithKline GABA Receptor Agonist Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 19. Biocodex Basic Information, Manufacturing Base and Competitors
Table 20. Biocodex GABA Receptor Agonist Drug Major Business
Table 21. Biocodex GABA Receptor Agonist Drug Total Revenue (USD Million) (2018-2019)
Table 22. Biocodex SWOT Analysis
Table 23. Biocodex GABA Receptor Agonist Drug Product and Services
Table 24. Biocodex GABA Receptor Agonist Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 25. AstraZeneca Basic Information, Manufacturing Base and Competitors
Table 26. AstraZeneca GABA Receptor Agonist Drug Major Business
Table 27. AstraZeneca GABA Receptor Agonist Drug Total Revenue (USD Million) (2018-2019)
Table 28. AstraZeneca SWOT Analysis
Table 29. AstraZeneca GABA Receptor Agonist Drug Product and Services
Table 30. AstraZeneca GABA Receptor Agonist Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 31. H.LundBeck, Merck and Co Basic Information, Manufacturing Base and Competitors
Table 32. H.LundBeck, Merck and Co GABA Receptor Agonist Drug Major Business
Table 33. H.LundBeck, Merck and Co GABA Receptor Agonist Drug Total Revenue (USD Million) (2018-2019)
Table 34. H.LundBeck, Merck and Co SWOT Analysis
Table 35. H.LundBeck, Merck and Co GABA Receptor Agonist Drug Product and Services
Table 36. H.LundBeck, Merck and Co GABA Receptor Agonist Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 37. Athena Drug Delivery Solutions Basic Information, Manufacturing Base and Competitors
Table 38. Athena Drug Delivery Solutions GABA Receptor Agonist Drug Major Business
Table 39. Athena Drug Delivery Solutions GABA Receptor Agonist Drug Total Revenue (USD Million) (2018-2019)
Table 40. Athena Drug Delivery Solutions SWOT Analysis
Table 41. Athena Drug Delivery Solutions GABA Receptor Agonist Drug Product and Services
Table 42. Athena Drug Delivery Solutions GABA Receptor Agonist Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 43. Novartis Basic Information, Manufacturing Base and Competitors
Table 44. Novartis GABA Receptor Agonist Drug Major Business
Table 45. Novartis GABA Receptor Agonist Drug Total Revenue (USD Million) (2018-2019)
Table 46. Novartis SWOT Analysis
Table 47. Novartis GABA Receptor Agonist Drug Product and Services
Table 48. Novartis GABA Receptor Agonist Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 49. Eli Lilly and Company Basic Information, Manufacturing Base and Competitors
Table 50. Eli Lilly and Company GABA Receptor Agonist Drug Major Business
Table 51. Eli Lilly and Company GABA Receptor Agonist Drug Total Revenue (USD Million) (2018-2019)
Table 52. Eli Lilly and Company SWOT Analysis
Table 53. Eli Lilly and Company GABA Receptor Agonist Drug Product and Services
Table 54. Eli Lilly and Company GABA Receptor Agonist Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 55. Elan Corporation Basic Information, Manufacturing Base and Competitors
Table 56. Elan Corporation GABA Receptor Agonist Drug Major Business
Table 57. Elan Corporation GABA Receptor Agonist Drug Total Revenue (USD Million) (2018-2019)
Table 58. Elan Corporation SWOT Analysis
Table 59. Elan Corporation GABA Receptor Agonist Drug Product and Services
Table 60. Elan Corporation GABA Receptor Agonist Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 61. NovaDel Pharma Basic Information, Manufacturing Base and Competitors
Table 62. NovaDel Pharma GABA Receptor Agonist Drug Major Business
Table 63. NovaDel Pharma GABA Receptor Agonist Drug Total Revenue (USD Million) (2018-2019)
Table 64. NovaDel Pharma SWOT Analysis
Table 65. NovaDel Pharma GABA Receptor Agonist Drug Product and Services
Table 66. NovaDel Pharma GABA Receptor Agonist Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 67. VIVUS Basic Information, Manufacturing Base and Competitors
Table 68. VIVUS GABA Receptor Agonist Drug Major Business
Table 69. VIVUS GABA Receptor Agonist Drug Total Revenue (USD Million) (2018-2019)
Table 70. VIVUS SWOT Analysis
Table 71. VIVUS GABA Receptor Agonist Drug Product and Services
Table 72. VIVUS GABA Receptor Agonist Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 73. OVATION Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 74. OVATION Pharmaceuticals GABA Receptor Agonist Drug Major Business
Table 75. OVATION Pharmaceuticals GABA Receptor Agonist Drug Total Revenue (USD Million) (2018-2019)
Table 76. OVATION Pharmaceuticals SWOT Analysis
Table 77. OVATION Pharmaceuticals GABA Receptor Agonist Drug Product and Services
Table 78. OVATION Pharmaceuticals GABA Receptor Agonist Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 79. XenoPort Basic Information, Manufacturing Base and Competitors
Table 80. XenoPort GABA Receptor Agonist Drug Major Business
Table 81. XenoPort GABA Receptor Agonist Drug Total Revenue (USD Million) (2018-2019)
Table 82. XenoPort SWOT Analysis
Table 83. XenoPort GABA Receptor Agonist Drug Product and Services
Table 84. XenoPort GABA Receptor Agonist Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 85. sanofi-aventis Basic Information, Manufacturing Base and Competitors
Table 86. sanofi-aventis GABA Receptor Agonist Drug Major Business
Table 87. sanofi-aventis GABA Receptor Agonist Drug Total Revenue (USD Million) (2018-2019)
Table 88. sanofi-aventis SWOT Analysis
Table 89. sanofi-aventis GABA Receptor Agonist Drug Product and Services
Table 90. sanofi-aventis GABA Receptor Agonist Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 91. Osmotica Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 92. Osmotica Pharmaceutical GABA Receptor Agonist Drug Major Business
Table 93. Osmotica Pharmaceutical GABA Receptor Agonist Drug Total Revenue (USD Million) (2018-2019)
Table 94. Osmotica Pharmaceutical SWOT Analysis
Table 95. Osmotica Pharmaceutical GABA Receptor Agonist Drug Product and Services
Table 96. Osmotica Pharmaceutical GABA Receptor Agonist Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 97. Pfizer Basic Information, Manufacturing Base and Competitors
Table 98. Pfizer GABA Receptor Agonist Drug Major Business
Table 99. Pfizer GABA Receptor Agonist Drug Total Revenue (USD Million) (2018-2019)
Table 100. Pfizer SWOT Analysis
Table 101. Pfizer GABA Receptor Agonist Drug Product and Services
Table 102. Pfizer GABA Receptor Agonist Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 103. Global GABA Receptor Agonist Drug Sales by Manufacturer (2018-2019) (K Pcs)
Table 104. Global GABA Receptor Agonist Drug Revenue by Manufacturer (2018-2019) (USD Million)
Table 105. Global GABA Receptor Agonist Drug Sales by Regions (2015-2020) (K Pcs)
Table 106. Global GABA Receptor Agonist Drug Sales Market Share by Regions (2015-2020)
Table 107. Global GABA Receptor Agonist Drug Revenue by Regions (2015-2020) (USD Million)
Table 108. North America GABA Receptor Agonist Drug Sales by Countries (2015-2020) (K Pcs)
Table 109. North America GABA Receptor Agonist Drug Sales Market Share by Countries (2015-2020)
Table 110. North America GABA Receptor Agonist Drug Revenue by Countries (2015-2020) (USD Million)
Table 111. North America GABA Receptor Agonist Drug Revenue Market Share by Countries (2015-2020)
Table 112. Europe GABA Receptor Agonist Drug Sales by Countries (2015-2020) (K Pcs)
Table 113. Europe GABA Receptor Agonist Drug Sales Market Share by Countries (2015-2020)
Table 114. Europe GABA Receptor Agonist Drug Revenue by Countries (2015-2020) (USD Million)
Table 115. Asia-Pacific GABA Receptor Agonist Drug Sales by Regions (2015-2020) (K Pcs)
Table 116. Asia-Pacific GABA Receptor Agonist Drug Sales Market Share by Regions (2015-2020)
Table 117. Asia-Pacific GABA Receptor Agonist Drug Revenue by Regions (2015-2020) (USD Million)
Table 118. South America GABA Receptor Agonist Drug Sales by Countries (2015-2020) (K Pcs)
Table 119. South America GABA Receptor Agonist Drug Sales Market Share by Countries (2015-2020)
Table 120. South America GABA Receptor Agonist Drug Revenue by Countries (2015-2020) (USD Million)
Table 121. South America GABA Receptor Agonist Drug Revenue Market Share by Countries (2015-2020)
Table 122. Middle East & Africa GABA Receptor Agonist Drug Sales by Countries (2015-2020) (K Pcs)
Table 123. Middle East & Africa GABA Receptor Agonist Drug Sales Market Share by Countries (2015-2020)
Table 124. Middle East & Africa GABA Receptor Agonist Drug Revenue by Countries (2015-2020) (USD Million)
Table 125. Middle East & Africa GABA Receptor Agonist Drug Revenue Market Share by Countries (2015-2020)
Table 126. Global GABA Receptor Agonist Drug Sales by Type (2015-2020) (K Pcs)
Table 127. Global GABA Receptor Agonist Drug Sales Share by Type (2015-2020)
Table 128. Global GABA Receptor Agonist Drug Revenue by Type (2015-2020) (USD Million)
Table 129. Global GABA Receptor Agonist Drug Revenue Share by Type (2015-2020)
Table 130. Global GABA Receptor Agonist Drug Sales by Application (2015-2020) (K Pcs)
Table 131. Global GABA Receptor Agonist Drug Sales Share by Application (2015-2020)
Table 132. Global GABA Receptor Agonist Drug Sales Forecast by Regions (2021-2025) (K Pcs)
Table 133. Global GABA Receptor Agonist Drug Market Share Forecast by Regions (2021-2025)
Table 134. Global GABA Receptor Agonist Drug Sales Forecast by Type (2021-2025) (K Pcs)
Table 135. Global GABA Receptor Agonist Drug Market Share Forecast by Type (2021-2025)
Table 136. Global GABA Receptor Agonist Drug Sales Forecast by Application (2021-2025)
Table 137. Global GABA Receptor Agonist Drug Market Share Forecast by Application (2021-2025)
Table 138. Direct Channel Pros & Cons
Table 139. Indirect Channel Pros & Cons
Table 140. Distributors/Traders/ Dealers List
List of Figures
Figure 1. GABA Receptor Agonist Drug Picture
Figure 2. Global Sales Market Share of GABA Receptor Agonist Drug by Type in 2019
Figure 3. Bamaluzole Picture
Figure 4. Phenibut Picture
Figure 5. Baclofen Picture
Figure 6. Gaboxadol Picture
Figure 7. Klonopin (clonazepam) Picture
Figure 8. Tiagbine Picture
Figure 9. GABA Receptor Agonist Drug Sales Market Share by Application in 2018
Figure 10. Attention Deficit Hyperactivity Disorder (ADHD) Picture
Figure 11. Psychiatric Disorders and Depression Picture
Figure 12. Alzheimer Picture
Figure 13. Epilepsy and Seizure Picture
Figure 14. Anxiety and Sleep Disorders Picture
Figure 15. Obesity and Alcoholism Picture
Figure 16. Global GABA Receptor Agonist Drug Market Status and Outlook (2015-2025) (USD Million)
Figure 17. United States GABA Receptor Agonist Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 18. Canada GABA Receptor Agonist Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 19. Mexico GABA Receptor Agonist Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 20. Germany GABA Receptor Agonist Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 21. France GABA Receptor Agonist Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 22. UK GABA Receptor Agonist Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 23. Russia GABA Receptor Agonist Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 24. Italy GABA Receptor Agonist Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 25. China GABA Receptor Agonist Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 26. Japan GABA Receptor Agonist Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 27. Korea GABA Receptor Agonist Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 28. India GABA Receptor Agonist Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 29. Southeast Asia GABA Receptor Agonist Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 30. Australia GABA Receptor Agonist Drug Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 31. Brazil GABA Receptor Agonist Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 32. Egypt GABA Receptor Agonist Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 33. Saudi Arabia GABA Receptor Agonist Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 34. South Africa GABA Receptor Agonist Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 35. Turkey GABA Receptor Agonist Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 36. Global GABA Receptor Agonist Drug Sales Market Share by Manufacturer in 2019
Figure 37. Global GABA Receptor Agonist Drug Revenue Market Share by Manufacturer in 2019
Figure 38. Top 3 GABA Receptor Agonist Drug Manufacturer (Revenue) Market Share in 2019
Figure 39. Top 6 GABA Receptor Agonist Drug Manufacturer (Revenue) Market Share in 2019
Figure 40. Key Manufacturer Market Share Trend
Figure 41. Global GABA Receptor Agonist Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 42. Global GABA Receptor Agonist Drug Revenue and Growth Rate (2015-2020) (USD Million)
Figure 43. Global GABA Receptor Agonist Drug Revenue Market Share by Regions (2015-2020)
Figure 44. Global GABA Receptor Agonist Drug Revenue Market Share by Regions in 2018
Figure 45. North America GABA Receptor Agonist Drug Sales and Growth Rate (2015-2020)
Figure 46. Europe GABA Receptor Agonist Drug Sales and Growth Rate (2015-2020)
Figure 47. Asia-Pacific GABA Receptor Agonist Drug Sales and Growth Rate (2015-2020)
Figure 48. South America GABA Receptor Agonist Drug Sales and Growth Rate (2015-2020)
Figure 49. Middle East & Africa GABA Receptor Agonist Drug Sales and Growth Rate (2015-2020)
Figure 50. North America GABA Receptor Agonist Drug Revenue and Growth Rate (2015-2020) (USD Million)
Figure 51. North America GABA Receptor Agonist Drug Sales Market Share by Countries (2015-2020)
Figure 52. North America GABA Receptor Agonist Drug Sales Market Share by Countries in 2018
Figure 53. North America GABA Receptor Agonist Drug Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 54. North America GABA Receptor Agonist Drug Revenue Market Share by Countries in 2018
Figure 55. United States GABA Receptor Agonist Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 56. Canada GABA Receptor Agonist Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 57. Mexico GABA Receptor Agonist Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 58. Europe GABA Receptor Agonist Drug Revenue and Growth Rate (2015-2020) (USD Million)
Figure 59. Europe GABA Receptor Agonist Drug Revenue Market Share by Countries (2015-2020)
Figure 60. Europe GABA Receptor Agonist Drug Revenue Market Share by Countries in 2019
Figure 61. Germany GABA Receptor Agonist Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 62. UK GABA Receptor Agonist Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 63. France GABA Receptor Agonist Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 64. Russia GABA Receptor Agonist Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 65. Italy GABA Receptor Agonist Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 66. Asia-Pacific GABA Receptor Agonist Drug Revenue and Growth Rate (2015-2020) (USD Million)
Figure 67. Asia-Pacific GABA Receptor Agonist Drug Sales Market Share by Regions 2019
Figure 68. Asia-Pacific GABA Receptor Agonist Drug Revenue Market Share by Regions 2019
Figure 69. China GABA Receptor Agonist Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 70. Japan GABA Receptor Agonist Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 71. Korea GABA Receptor Agonist Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 72. India GABA Receptor Agonist Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 73. Southeast Asia GABA Receptor Agonist Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 74. South America GABA Receptor Agonist Drug Revenue and Growth Rate (2015-2020) (USD Million)
Figure 75. South America GABA Receptor Agonist Drug Sales Market Share by Countries in 2019
Figure 76. South America GABA Receptor Agonist Drug Revenue Market Share by Countries in 2019
Figure 77. Brazil GABA Receptor Agonist Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 78. Argentina GABA Receptor Agonist Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 79. Middle East and Africa GABA Receptor Agonist Drug Revenue and Growth Rate (2015-2020) (USD Million)
Figure 80. Middle East and Africa GABA Receptor Agonist Drug Sales Market Share by Countries in 2019
Figure 81. Middle East and Africa GABA Receptor Agonist Drug Revenue Market Share by Countries (2015-2020)
Figure 82. Middle East and Africa GABA Receptor Agonist Drug Revenue Market Share by Countries in 2019
Figure 83. Saudi Arabia GABA Receptor Agonist Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 84. Egypt GABA Receptor Agonist Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 85. Turkey GABA Receptor Agonist Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 86. South Africa GABA Receptor Agonist Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 87. Global GABA Receptor Agonist Drug Sales and Growth Rate (2021-2025) (K Pcs)
Figure 88. Global GABA Receptor Agonist Drug Revenue and Growth Rate (2021-2025) (USD Million)
Figure 89. North America Sales GABA Receptor Agonist Drug Market Forecast (2021-2025) (K Pcs)
Figure 90. Europe Sales GABA Receptor Agonist Drug Market Forecast (2021-2025) (K Pcs)
Figure 91. Asia-Pacific Sales GABA Receptor Agonist Drug Market Forecast (2021-2025) (K Pcs)
Figure 92. South America Sales GABA Receptor Agonist Drug Market Forecast (2021-2025) (K Pcs)
Figure 93. Middle East & Africa Sales GABA Receptor Agonist Drug Market Forecast (2021-2025) (K Pcs)
Figure 94. Sales Channel: Direct Channel vs Indirect Channel
グルカゴン様ペプチド-2（GLP-2）アゴニストの世界市場 2020年 Market Overview The global Glucagon-like Peptide-2 (GLP-2) Agonist market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Gluca…- GABAの世界市場 2020年 Market Overview The GABA market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulation…
- ゴナドトロピン放出ホルモンアゴニストの世界市場 2020年 Market Overview The global Gonadotropin-releasing Hormone Agonist market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Gonado…
- ゴナドトロピン放出ホルモン作動薬の世界市場 2020年 Market Overview The global Gonadotropin-releasing Hormone Agonist Drugs market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The …
- アルファ2Cアドレナリン受容体の世界市場 2020年 Market Overview The global Alpha 2C Adrenergic Receptor market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Alpha 2C Adrener…